Saturday, July 01, 2017 8:28:26 AM
Recent XENE News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:09:29 PM
- Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 08:01:00 PM
- Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 • GlobeNewswire Inc. • 05/08/2024 08:01:00 PM
- Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/07/2024 08:01:00 PM
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 05/02/2024 08:01:00 PM
- Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/16/2024 12:30:00 PM
- Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days • GlobeNewswire Inc. • 03/12/2024 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 11:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:31:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:28:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:27:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 12:04:19 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 12:03:52 AM
- Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:10:54 PM
- Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:12:03 PM
- Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:41:00 PM
- Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 12/04/2023 09:16:53 PM
- Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023) • GlobeNewswire Inc. • 12/02/2023 05:01:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM